European eating disorders review : the journal of the Eating Disorders Association · 2026
Comorbid Depression in Hospitalised Youth With Anorexia Nervosa: Characteristics, Correlates, and Impact on Weight Gain and Treatment Duration.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wiese Antonia, Arnold Sabine, Zaid Sarah, Müller Antonia E, Correll Christoph U, Jaite Charlotte
Аннотация
OBJECTIVE: Anorexia nervosa (AN) is associated with high rates of comorbidities. The impact of comorbid depression-spectrum disorders (DSDs) in AN patients on the outcomes of inpatient treatment is insufficiently studied.
METHOD: Retrospective study of youth with AN (9-18 years), admission weight < 10th body mass index (BMI) percentile, consecutively hospitalised in a child and adolescent psychiatry university department. Patients with AN+DSD as the only psychiatric comorbidity were compared with AN patients without psychiatric comorbidity (ANnoComorbidity).
RESULTS: Among 220 female AN inpatients (median = 15.0 years) 62 had AN+DSD versus 158 had ANnoComorbidity. Patients with AN+DSD were more likely to report childhood emotional abuse (p = 0.020), and to receive psychotropic medications (any: p < 0.001; antidepressants: p < 0.001; antipsychotics: p = 0.001). Moreover, AN+DSD had less average weekly weight gain (p = 0.012) and longer inpatient treatment (p < 0.001). Independent correlates of less average weekly weight gain included lower admission BMI z-score (p < 0.001), antipsychotic (p = 0.002) and antidepressant (p = 0.004) treatment (R2 = 0.17, p < 0.001). Independent correlates of longer hospitalisation included lower admission BMI z-scores (p < 0.001), antipsychotic (p < 0.001) or antidepressant (p < 0.001) treatment (R2 = 0.27, p < 0.001).
CONCLUSION: AN+DSD were hospitalised longer and gained less average weight/week compared to ANnoComorbidity. Lower admission weight, antipsychotic or antidepressant co-treatment were independently associated with less average weight gain and longer inpatient stays.
METHOD: Retrospective study of youth with AN (9-18 years), admission weight < 10th body mass index (BMI) percentile, consecutively hospitalised in a child and adolescent psychiatry university department. Patients with AN+DSD as the only psychiatric comorbidity were compared with AN patients without psychiatric comorbidity (ANnoComorbidity).
RESULTS: Among 220 female AN inpatients (median = 15.0 years) 62 had AN+DSD versus 158 had ANnoComorbidity. Patients with AN+DSD were more likely to report childhood emotional abuse (p = 0.020), and to receive psychotropic medications (any: p < 0.001; antidepressants: p < 0.001; antipsychotics: p = 0.001). Moreover, AN+DSD had less average weekly weight gain (p = 0.012) and longer inpatient treatment (p < 0.001). Independent correlates of less average weekly weight gain included lower admission BMI z-score (p < 0.001), antipsychotic (p = 0.002) and antidepressant (p = 0.004) treatment (R2 = 0.17, p < 0.001). Independent correlates of longer hospitalisation included lower admission BMI z-scores (p < 0.001), antipsychotic (p < 0.001) or antidepressant (p < 0.001) treatment (R2 = 0.27, p < 0.001).
CONCLUSION: AN+DSD were hospitalised longer and gained less average weight/week compared to ANnoComorbidity. Lower admission weight, antipsychotic or antidepressant co-treatment were independently associated with less average weight gain and longer inpatient stays.